India's paradox: The largest drug exporter and the most isolationist drug industry

Shutterstock.com

Article Highlights

  • Dangerous or not, India’s pharmaceutical industry continues to grow because of price.

    Tweet This

  • India’s main problem now is that nationalism has replaced health protection as the guiding principle of drug regulation.

    Tweet This

  • Enforcement on adulterated drugs cannot be different in #India just because good manufacturing practices are so laxly interpreted there.

    Tweet This

The reach of the Indian pharmaceutical industry is enormous. India supplies a large and increasing amount of the generic drugs sold globally, and the country is home to over 150 drug manufacturing facilities approved by the US Food and Drug Administration1—including many run by multinational players. The value of pharmaceutical exports from India to the United States rose nearly 32 percent in 2012, to $4.2 billion.2 India supplies nearly 40 percent of generic drugs and over-the-counter products as well as 10 percent of finished dosages used in the US.3 Some of these products are very substantial: Ranbaxy, one of India’s largest pharmaceutical companies, won the right to make the only generic version of Lipitor for sale to Americans when it was the world’s best selling drug with peak annual sales of over $12 billion.4 India is one of the largest suppliers for the Internet market in western countries and is the dominant provider in most emerging markets, too.

India's paradox: The largest drug exporter and the most isolationist drug industry by American Enterprise Institute

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

AEI Election Watch 2014: What will happen and why it matters
image A nation divided by marriage
image Teaching reform
image Socialist party pushing $20 minimum wage defends $13-an-hour job listing
AEI on Facebook
Events Calendar
  • 27
    MON
  • 28
    TUE
  • 29
    WED
  • 30
    THU
  • 31
    FRI
Monday, October 27, 2014 | 10:00 a.m. – 11:30 a.m.
State income taxes and the Supreme Court: Maryland Comptroller v. Wynne

Please join AEI for a panel discussion exploring these and other questions about this crucial case.

Tuesday, October 28, 2014 | 9:30 a.m. – 12:15 p.m.
For richer, for poorer: How family structures economic success in America

Join Lerman, Wilcox, and a group of distinguished scholars and commentators for the release of Lerman and Wilcox’s report, which examines the relationships among and policy implications of marriage, family structure, and economic success in America.

Tuesday, October 28, 2014 | 5:30 p.m. – 7:00 p.m.
The 7 deadly virtues: 18 conservative writers on why the virtuous life is funny as hell

Please join AEI for a book forum moderated by Last and featuring five of these leading conservative voices. By the time the forum is over, attendees may be on their way to discovering an entirely different — and better — moral universe.

Thursday, October 30, 2014 | 2:00 p.m. – 3:00 p.m.
A nuclear deal with Iran? Weighing the possibilities

Join us, as experts discuss their predictions for whether the United States will strike a nuclear deal with Iran ahead of the November 24 deadline, and the repercussions of the possible outcomes.

Thursday, October 30, 2014 | 5:00 p.m. – 6:15 p.m.
The forgotten depression — 1921: The crash that cured itself

Please join Author James Grant and AEI senior economists for a discussion about Grant's book, "The Forgotten Depression: 1921: The Crash That Cured Itself" (Simon & Schuster, 2014).

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.